Negative SARS-CoV-2 antibody testing following COVID-19 infection in Two MS patients treated with ocrelizumab
Jeanine Rempe Thornton, Asaff Harel
Topics & Concepts
MedicineOcrelizumabCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Multiple sclerosis2019-20 coronavirus outbreakVirologyBetacoronavirusAntibodyImmunologyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseRituximabSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19COVID-19 Clinical Research Studies